Conjugated Linoleic Acid and Bone Biology

Journal of the American College of Nutrition

Volumn 19, Issue 4, 2000, Pages 478S-486S

  Watkins, Bruce A ^a   Seifert, Mark F ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Bone; Cartilage; Conjugated linoleic acid; Rat

Indexed keywords

CYTOKINE; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; BONE GROWTH; BONE REMODELING; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL FUNCTION; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME ACTIVITY; FAT INTAKE; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOPOROSIS; PROTEIN EXPRESSION; RAT; REVIEW;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE REMODELING; CARTILAGE; CYTOKINES; DIETARY FATS, UNSATURATED; HUMANS; LINOLEIC ACID; PROSTAGLANDINS;

ANIMALIA;

EID: 0033884814     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2000.10718951     Document Type: Article

References (72)

1. Baron R: Anatomy and ultrastructure of bone. In Favus MJ: “αPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,” 2nd ed. New York: Raven Press, pp 3-9, 1993.
2. Baylink DJ, Finkelman RD, Mohan S: Growth factors to stimulate bone formation. J Bone Miner Res 8: S565-S572, 1993.
3. Mundy GR: Cytokines and growth factors in the regulation of bone remodeling. J Bone Miner Res 8: S505-S510, 1993.
4. Raisz LG: Bone cell biology: new approaches and unanswered questions. J Bone Miner Res 8: S457-S465, 1993.
5. Canalis B: Regulation of bone remodeling. In Favus MJ: “αPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,” 2nd ed. New York: Raven Press, pp 33-37, 1993.
6. Blair HC, Schlesinger PH, Ross FP, Teitelbaum SL: Recent advances toward understanding osteoclast physiology. Clin Orthop 294: 7-22, 1993.
7. Frost HM: “αBone Remodeling and its Relationship to Metabolic Bone Disease.” Springfield, IL: Thomas, pp 28-53, 1993.
8. Frost HM: “αBone Remodeling Dynamics.” Springfield, IL: Thomas, 1963.
9. Kanis JA (ed): “αVol 4: Calcium Metabolism.” In Parfitt AM (ed): “αProgress in Basic and Clinical Pharmacology.” Basel: Karger, pp 1-27, 1990.
10. Watrous DA, Andrews BS: The metabolism and immunology of bone. Semin Arthritis Rheum 19: 45-65, 1989.
11. Nilsson A, Ohlsson C, Isaksson OG, Lindahl A, Isgaard J: Hormonal regulation of longitudinal bone growth. Eur J Clin Nutr 48: S150-S160, 1994.
12. Chow J, Tobias JH, Colston KW, Chambers TJ: Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89: 74-78, 1992.
13. Raisz LO: Recent advances in bone cell biology: Interactions of vitamin D with other local and systemic factors. J Bone Miner Res 9: 191-197, 1990.
14. Kream BE, Petersen DN, Raisz LG: Parathyroid hormone blocks the stimulatory effect of insulin-like growth factor-I on collagen synthesis in cultured 21-day fetal rat calvariae. Bone 11: 411-415, 1990.
15. Klaushofer K, Hoffmann O, Gleispach H, Leis H-J, Czerwenka E, Koller K, Peterlik M: Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res 4: 305-312, 1989.
16. Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112: 352-364, 1990.
17. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF Jr, Lodish HF, Goldring SR: Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254: 1022-1024, 1991.
18. Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H: Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblastlike cell, MC3T3-E1. Prostaglandins Leukot Essent Fatty Acids 50: 169-172, 1994.
19. Marks SC, Miller SC: Prostaglandins and the skeleton: the legacy and challenges of two decades of research. Endocrine J 1: 337-344, 1993.
20. Canalis E, Centrella M, McCarthy TL: Regulation of the insulinlike growth factor-II production in bone cultures. Endocrinology 129: 2457-2462, 1991.
21. Mohan S, Baylink DJ: Bone growth factors. Clin Orthop 263: 30-48, 1991.
22. McCarthy TL, Centrella M, Raisz LG, Canalis E: Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblastenriched cultures from fetal rat bone. Endocrinology 128: 2895-2900, 1991.
23. Norrdin RW, Jee WS, High WB: The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids 41: 139-149, 1990.
24. Parodi PW: Cows’ milk fat components as possible anticarcinogenic agents. J Nutr 127, 1055-1060: 1997.
25. Ip C: Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am J Clin Nutr 66: 1523S-1529S, 1997.
26. Ip C, Jiang C, Thompson HJ, Scimeca JA: Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis 18: 755-759, 1997.
27. Cunningham DC, Harrison LY, Schultz TD: Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res 17: 197-204, 1997.
28. Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, Kritchevsky D: Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res 17: 969-974, 1997.
29. Sehat N, Yurawecz MP, Roach JAG, Mossoba MM, Kramer JKG, Ku Y: Silver-ion high-performance liquid chromatographic separation and identification of conjugated linoleic acid isomers. Lipids 33: 217-221, 1998.
30. Kramer JKG, Parodi PW, Jensen RG, Mossoba MM, Yurawecz MP, Adlof RO: Rumenic acid: A proposed common name for the major conjugated linoleic acid isomer found in natural products. Lipids 33: 835, 1998.
31. Ha YL, Storkson J, Pariza MW: Inhibition of benzo(a)pyreneinduced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 50: 1097-1101, 1990.
32. Cornell KK, Waters DJ, Coffman KT, Robinson JP, Watkins BA: Conjugated linoleic acid inhibited the in vitro proliferation of canine prostate cancer cells. FASEB 11: A579 (Abstract), 1997.
33. Li Y, Watkins BA: Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids 33: 417-425, 1998.
34. Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KDG, Watkins BA: Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 14: 1153-1162, 1999.
35. Turek JJ, Li Y, Schoenlein IA, Allen KGD, Watkins BA: Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6: n-3 fatty acid ratio. J Nutr Biochem 9: 258-266, 1998.
36. Sugano M, Tsujita A, Yamasaki M, Yamada K, Ikeda I, Kritchevsky D: Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem 8: 38-43, 1997.
37. Sugano M, Tsujita A, Yamasaki M, Noguchi M, Yamada K: Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 33: 521-527, 1998.
38. Wuthier RE: Involvement of cellular metabolism of calcium and phosphate in calcification of avian growth plate cartilage. J Nutr 121: 301-309, 1993.
39. Gunnes M, Lehmann EH: Dietary calcium, saturated fat, fiber and vitamin C as predictors of forearm cortical and trabecular bone mineral density in healthy children and adolescents. Act Paediatr 84: 388-392, 1995.
40. Watkins BA, Shen C-L, Allen KGD, Seifert MF: Dietary (n-3) and (n-6) polyunsaturates and acetylsalicylic acid alter ex vivo PGE2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 11: 1321-1332, 1996.
41. Watkins BA, Shen C-L, McMurtry JP, Xu H, Bain SD, Allen KGD, Seifert MF: Dietary lipids modulate bone prostaglandin E2 production, insulin-like growth factor-I concentration and formation rate in chicks. J Nutr 127: 1084-1091, 1997.
42. Hodgson JM, Wahlqvist ML, Boxall JA, Balazs ND: Can linoleic acid contribute to coronary artery disease? Am J Clin Nutr 58: 228-234, 1993.
43. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL: Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr 54: 701-706, 1991.
44. Watkins BA: Regulatory effects of polyunsaturates on bone modeling and cartilage function. World Rev Nutr Dietetics 83: 38-51, 1998.
45. McCarthy TL, Ji C, Casinghino S, Centrella M: Alternate signaling pathways selectively regulate binding of insulin-like growth factor I and II on fetal rat bone cells. J Cell Biochem 68: 446-456, 1998.
46. Xu H, Watkins BA, Adkisson HD: Dietary lipids modify the fatty acid composition of cartilage, isolated chondrocytes and matrix vesicles. Lipids 29: 619-625, 1994.
47. Xu H, Watkins BA, Seifert MF: Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry. Calcif Tissue Int 57: 293-300, 1995.
48. Watkins BA, Xu H, Turek JJ: Linoleate impairs collagen synthesis in primary cultures of avian chondrocytes. Proc Soc Exp Biol Med 212: 153-159, 1996.
49. Adkisson HD, Risener FS, Zarrinkar PP, Walla MD, Christie WW, Wuthier RE: Unique fatty acid composition of normal cartilage: discovery of high n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. FASEB J 5: 344-353, 1991.
50. Seifert MF, Watkins BA: Role of dietary lipid and antioxidants in bone metabolism. Nutr Res 17: 1209-1228, 1997.
51. Watkins BA, Seifert MF, Allen KGD: Importance of dietary fat in modulating PGE2 responses and influence of vitamin E on bone morphometry. World Rev Nutr Diet 82: 250-259, 1997.
52. Chen Y: “αModulatory Aspects of Polyunsaturated Fatty Acids on Epiphyseal Chondrocyte Function.” [MS Thesis.] West Lafayette, IN: Purdue University, 1997.
53. Ip C, Briggs SP, Haegele AD, Thompson HJ, Storkson J, Scimeca JA: The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. Carcinogenesis 17: 1045-1050, 1996.
54. Maciel FMB, Sarrazin P, Morisset S, Lora M, Patry C, Dumais R, Debrumfernandes AJ: Induction of cyclooxygenase-2 by parathyroid hormone in human osteoblasts in culture. J Rheumatol 24: 2429-2435, 1997.
55. Suda M, Tanaka K, Yasoda A, Natsui K, Sakuma Y, Tanaka I, Ushikubi F, Narumiya S, Nakao K: Prostaglandin E2 (PGE2) autoamplifies its production through EP 1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Calcif Tissue Int 62: 327-331, 1998.
56. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao SP, Khwaja S, Tahan SR, Dannenberg AJ: Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor-alpha and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26: 1538-1545, 1997.
57. Singh J, Hamid R, Reddy BS: Dietary fat and colon cancer-modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57: 3465-3470, 1997.
58. Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J: Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22: 309-316, 1998.
59. Ono K, Akatsu T, Murakami T, Nishikawa M, Yamamoto M, Kugai N, Motoyoshi K, Nagata N: Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2. J Endocrinol 158: R1-R5, 1998.
60. Prunzanski W, Stefanski E, Vadas P, Kennedy BP, van den Bosch H: Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factor. Biochim Biophys Acta 1403: 47-56, 1998.
61. Sebedio JL, Juaneda P, Dobson G, Ramilison I, Martin JC, Chardigny JM, Christie WW: Metabolites of conjugated isomers of linoleic acid (CLA) in the rat. Biochim Biophys Acta 1345: 5-10, 1997.
62. Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305-315, 1990.
63. Pacifici R, Rifas L, McCracken R, Vered I, McMurty C, Avioli LV, Peck WA: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86: 2398-2402, 1989.
64. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC: 17b-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89: 883-891, 1992.
65. Garcia C, Boyce BF, Gilles J, Dallas M, Qiao M, Mundy GR, Bonewald LF: Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 11: 1619-1627, 1996.
66. Kremer JM: Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 31: S243-S247, 1996.
67. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J: Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum 37: 824-829, 1994.
68. Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL: Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology 7: 256-263, 1996.
69. Rose DP: Dietary fatty acids and prevention of hormoneresponsive cancer. Proc Soc Exp Biol Med 216: 224-233, 1997.
70. Marks F, Furstenberger G, Muller-Decker K: Arachidonic acid metabolism as a reporter of skin irritancy and target of cancer chemoprevention. Toxicol Lett 96-97: 111-118, 1998.
71. Orr FW, Kostenuik P, Sanchez-Sweatman OH, Singh G: Mechanisms involved in the metastasis of cancer to bone. Breast Cancer Res Treat 25: 151-163, 1993.
72. Hamilton LC, Mitchell JA, Tomlinson AM, Warner TD: Synergy between cyclooxygenase-2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal anti-inflammatory drug efficacy. FASEB J 13: 245-251, 1999.